I am also launching my live version that includes Facebook group support and weekly Q&As with me and my team nutritionist
doi: 10.1056/NEJMoa1905795 [PubMed] 32049893 Barra ME, Phillips KM, Chung DY, Rosenthal ES
Abbvie: Speaking and Teaching, JOAQUIN CABEZAS: Gilead: Advisor, Gilead: Speaking and Teaching, Abbvie: Speaking and Teaching, MARTA CASADO MARTIN: Nothing to Disclose, Mohamed Alzaabi: Nothing to Disclose, Aastha Chandak: Certara: Employee, Certara: Stock - publicly traded company, Gilead Sciences: My institution (Certara) was contracted by Gilead for study, Marta Martinez: Nothing to Disclose, Artak Khachatryan: Nothing to Disclose, Linda Chen: Nothing to Disclose, Candido Hernandez: Gilead Sciences: Employee, YU JUN WONG: Nothing to Disclose 505 EVALUATION OF HEPATITIS C TREATMENT AND CARE MODEL IN PRIMARY HEALTHCARE CENTERS IN THE COUNTRY OF GEORGIA Akaki Abutidze 1 Tengiz Tsertsvadze 1 Lali Sharvadze 2 Rania A
Homozygous mutation in SLO3 leads to severe asthenoteratozoospermia due to acrosome hypoplasia and mitochondrial sheath malformations